Update on acquisition of China Joint Venture

30 April 2019

Update on acquisition of remaining 49% of China Joint Venture

Comvita (NZX:CVT) announced today that further to our announcement of 10 April 2019, the parties have
extended the conditional date from 30 April 2019 to 31 May 2019 (with further provision to extend this date by
agreement). The transaction remains conditional upon the following material conditions:

• Confirmatory due diligence to be completed to Comvita’s satisfaction;
• Compliance with all legal requirements;
• Issuance of an updated Business Licence for the JV;
• Confirmation of the continuation of all material contracts of the JV.

Completion will occur three Business Days after satisfaction of all transaction conditions.



Ends

For further information:
Comvita CEO, Scott Coulter, 021 386 988
Comvita Chair, Neil Craig, 021 731 509

Background information:
About Comvita (www.comvita.co.nz)
Comvita (NZX:CVT) is a global natural health company committed to the development of innovative
products, backed by ongoing investment in scientific research.